Using dose-response characteristics of therapeutic agents for treatment decisions in type 2 diabetes

[21] EFFECT OF SULFONYLUREA ON GLUCOSE-STIMULATED INSULIN-SECRETION IN HEALTHY AND NON-INSULIN-DEPENDENT DIABETIC SUBJECTS - A DOSE-RESPONSE STUDY [J]. ACTA DIABETOLOGICA, 1991, 28 (02) : 162 - 168

[22] HAUPT E, 1991, DIABETES METAB, V17, P224

[23] ANTIHYPERGLYCEMIC EFFICACY, RESPONSE PREDICTION AND DOSE-RESPONSE RELATIONS OF TREATMENT WITH METFORMIN AND SULFONYLUREA, ALONE AND IN PRIMARY COMBINATION [J]. DIABETIC MEDICINE, 1994, 11 (10) : 953 - 960

[24] THERAPEUTIC COMPARISON OF METFORMIN AND SULFONYLUREA, ALONE AND IN VARIOUS COMBINATIONS - A DOUBLE-BLIND CONTROLLED-STUDY [J]. DIABETES CARE, 1994, 17 (10) : 1100 - 1109

[25] SELECTIVE UNRESPONSIVENESS OF PANCREATIC BETA-CELLS TO ACUTE SULFONYLUREA STIMULATION DURING SULFONYLUREA THERAPY IN NIDDM [J]. DIABETES, 1986, 35 (12) : 1314 - 1320

[26] Kikuchi M, 1996, DIABETIC MED, V13, pS151

[27] COMPARATIVE TOLERABILITY PROFILES OF ORAL ANTIDIABETIC AGENTS [J]. DRUG SAFETY, 1994, 11 (04) : 223 - 241

[28] Kumar S, 1998, DIABETIC MED, V15, P772, DOI 10.1002/(SICI)1096-9136(199809)15:9<772::AID-DIA677>3.0.CO

[29] 2-X

[30] Kumar S, 1996, DIABETOLOGIA, V39, P701

[21] EFFECT OF SULFONYLUREA ON GLUCOSE-STIMULATED INSULIN-SECRETION IN HEALTHY AND NON-INSULIN-DEPENDENT DIABETIC SUBJECTS - A DOSE-RESPONSE STUDY [J]. ACTA DIABETOLOGICA, 1991, 28 (02) : 162 - 168

[22] HAUPT E, 1991, DIABETES METAB, V17, P224

[23] ANTIHYPERGLYCEMIC EFFICACY, RESPONSE PREDICTION AND DOSE-RESPONSE RELATIONS OF TREATMENT WITH METFORMIN AND SULFONYLUREA, ALONE AND IN PRIMARY COMBINATION [J]. DIABETIC MEDICINE, 1994, 11 (10) : 953 - 960

[24] THERAPEUTIC COMPARISON OF METFORMIN AND SULFONYLUREA, ALONE AND IN VARIOUS COMBINATIONS - A DOUBLE-BLIND CONTROLLED-STUDY [J]. DIABETES CARE, 1994, 17 (10) : 1100 - 1109

[25] SELECTIVE UNRESPONSIVENESS OF PANCREATIC BETA-CELLS TO ACUTE SULFONYLUREA STIMULATION DURING SULFONYLUREA THERAPY IN NIDDM [J]. DIABETES, 1986, 35 (12) : 1314 - 1320

[26] Kikuchi M, 1996, DIABETIC MED, V13, pS151

[27] COMPARATIVE TOLERABILITY PROFILES OF ORAL ANTIDIABETIC AGENTS [J]. DRUG SAFETY, 1994, 11 (04) : 223 - 241

[28] Kumar S, 1998, DIABETIC MED, V15, P772, DOI 10.1002/(SICI)1096-9136(199809)15:9<772::AID-DIA677>3.0.CO

[29] 2-X

[30] Kumar S, 1996, DIABETOLOGIA, V39, P701